Exploring Molecule Basket Offerings in the Pharmaceutical Industry
11/06/2025
One of our clients is looking to connect with an expert in the commercial and strategic expansion space within the global pharmaceutical industry. They are looking to understand the revenue expansion dynamics, therapeutic portfolio landscape, competitive landscape, future outlook, challenges and best practices of key players in this industry—particularly in relation to selling both large molecules and small molecules as basket products across therapy areas such as Oncology, Immunology, Diabetes, and Obesity. Experts who have previously worked with key players like Roche Holding AG, Novartis AG, AstraZeneca plc, Sanofi S.A., Eli Lilly and Company etc. would be ideal.
